CSRxP APPLAUDS REINTRODUCTION OF REMEDY ACT IN U.S. SENATE
Bipartisan, Market-Based Solution Would Help Crack Down on Anti-Competitive… Read More
© 2025 CSRXP- All Rights Reserved
BIG PHARMA EARNINGS: SANOFI, ASTRAZENECA, ROCHE AND ABBVIE
More Brand Name Drug Makers Beat Wall Street Earnings After Hiking Prices This… Read More
BIG PHARMA EARNINGS: JOHNSON & JOHNSON AND NOVARTIS
Big Pharma Giants Top Wall Street Expectations After Hiking Prices on… Read More
CSRXP: BIG PHARMA IS AT IT AGAIN, HIKES PRICES ON NEARLY 200 PRESCRIPTION DRUGS AS PART OF MID-YEAR INCREASES
Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate… Read More
ICYMI: SENATOR CORNYN DELIVERS REMARKS ON U.S. SENATE PASSAGE OF PATENT THICKET CRACKDOWN
Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma… Read More
CSRXP APPLAUDS U.S. SENATE PASSAGE OF BIPARTISAN, MARKET-BASED SOLUTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS
Legislation Would Hold Big Pharma Accountable for Anti-Competitive Tactics… Read More
NEW GOODRX REPORT UNDERSCORES NEED FOR CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE
Latest Data Finds List Prices of Prescription Drug Prices Have Increased… Read More
SECOND OPINION: LATEST PHRMA AD CAMPAIGN DEFENDS PATENT ABUSE “STATUS QUO”
Big Pharma Advertising Blitz Seeks to Protect Anti-Competitive Tactics That… Read More
DOSE OF REALITY: FORBES: HOW BIG PHARMA EXPLOITS LOOPHOLES IN THE PATENT SYSTEM
Avik Roy Highlights How Increased USPTO-FDA Collaboration and Greater Scrutiny… Read More
SECOND OPINION: BIG PHARMA’S EGREGIOUS PRICING PRACTICES AND ANTI-COMPETITIVE TACTICS ARE THE ROOT CAUSE OF HIGH DRUG PRICES
Breaking Down the Facts on Drug Prices, Innovation, Patent Abuse… Read More
DOSE OF REALITY: FORBES: MAKING IT HARDER TO CHALLENGE BIG PHARMA’S PATENT THICKETS WOULD RAISE DRUG PRICES, UNDERMINE TRUE INNOVATION
Research Article Explores Negative Implications of Proposal to Restrict Key… Read More
DOSE OF REALITY: FORBES: HOW BIG PHARMA STIFLES COMPETITION WITH PRODUCT HOPPING
Research Column Explores Case Study in Common Patent Abuse Tactic That… Read More